CD274 and cancer: Increased PD-L1-mediated immune suppression and reduced HLA-ABC expression impaired T-cell-mediated lysis of cancer cells as well as antigen-presenting ability, and cooperated to promote immune evasion, and more aggressive clinicopathological features [74,75].